痤疮治疗药物市场报告：2030 年趋势、预测和竞争分析

痤疮治疗药物的趋势和预测

2024年至2030年，全球痤疮治疗市场预计复合年增长率为4.2%。这个市场的主要驱动因素是生活方式的改变和皮肤病的增加。全球痤疮治疗市场前景广阔，在外用製剂、口服和注射市场充满机会。

痤疮治疗药物按细分市场

本研究按类型、治疗层级、给药方法和地区对全球痤疮治疗进行了预测。

痤疮治疗市场洞察

Lucintel 预测，由于细菌感染病例的增加，在预测期内，发炎疾病仍将是最大的部分。

外用製剂仍然是这个市场中最大的部分。

由于生活方式的改变和疾病盛行率的增加，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球痤疮治疗市场预计复合年增长率为4.2%。

Q2. 影响市场成长的关键驱动因素是：

A2.该市场的主要驱动因素是生活方式的改变和皮肤病的增加。

Q3.市场的主要细分市场是：

A3. 痤疮治疗市场前景广阔，外用製剂、口服和注射药物市场都有机会。

Q4.市场的主要企业是：

A4. 主要治疗痤疮的药物公司如下：

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计，由于细菌感染病例的增加，在预测期内，发炎疾病仍将是最大的部分。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于生活方式的改变和疾病盛行率的增加，北美在预测期内仍然是最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球痤疮治疗市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球痤疮治疗药物市场趋势（2018-2023）和预测（2024-2030）
• 按类型分類的全球痤疮治疗药物市场
  • 致粉刺的
  • 发炎的
  • 囊状的
  • 手术后/伤口
• 按治疗层级的全球痤疮治疗药物市场
  • 类视色素A
  • 抗生素
  • 荷尔蒙药物
  • 组合
  • 其他的
• 按给药方法分類的全球痤疮治疗药物市场
  • 局部的
  • 口服
  • 注射

第四章 2018-2030年区域市场趋势及预测分析

• 全球痤疮治疗药物市场（按地区）
• 北美痤疮治疗市场
• 欧洲痤疮治疗市场
• 亚太地区痤疮治疗市场
• 其他地区痤疮治疗药物市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
• 全球痤疮治疗市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球痤疮治疗市场产能
  • 全球痤疮治疗市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Trends and Forecast

The future of the global acne drug market looks promising with opportunities in the topical, oral, and injectable markets. The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are changing lifestyle and increasing dermatological diseases.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Acne Drug by Segment

The study includes a forecast for the global acne drug by type, therapeutic class, mode of administration, and region.

Acne Drug Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Comedonal
• Inflammatory
• Cystic
• Postsurgical/Wound

Acne Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

• Retinoid
• Antibiotic
• Hormonal Agent
• Combination
• Others

Acne Drug Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Oral
• Injectable

Acne Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acne Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acne drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acne drug companies profiled in this report include-

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Market Insights

Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Within this market, topical will remain the largest segment.

North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Features of the Global Acne Drug Market

Market Size Estimates: Acne drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acne drug market size by type, therapeutic class, mode of administration, and region in terms of value ($B).

Regional Analysis: Acne drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, therapeutic classes, mode of administration, and regions for the acne drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acne drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for acne drug market?

Answer: The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the acne drug market?

Answer: The major drivers for this market are changing lifestyle and increasing dermatological diseases.

Q3. What are the major segments for acne drug market?

Answer: The future of the acne drug market looks promising with opportunities in the topical, oral, and injectable markets.

Q4. Who are the key acne drug market companies?

Answer: Some of the key acne drug companies are as follows:

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5. Which acne drug market segment will be the largest in future?

Answer: Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Q6. In acne drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acne drug market by type (comedonal, inflammatory, cystic, and postsurgical/wound), therapeutic class (retinoid, antibiotic, hormonal agent, combination, and others), mode of administration (topical, oral, and injectable), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acne Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acne Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acne Drug Market by Type
  • 3.3.1: Comedonal
  • 3.3.2: Inflammatory
  • 3.3.3: Cystic
  • 3.3.4: Postsurgical/Wound
• 3.4: Global Acne Drug Market by Therapeutic Class
  • 3.4.1: Retinoid
  • 3.4.2: Antibiotic
  • 3.4.3: Hormonal Agent
  • 3.4.4: Combination
  • 3.4.5: Others
• 3.5: Global Acne Drug Market by Mode of Administration
  • 3.5.1: Topical
  • 3.5.2: Oral
  • 3.5.3: Injectable

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acne Drug Market by Region
• 4.2: North American Acne Drug Market
  • 4.2.1: North American Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.2.2: North American Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.3: European Acne Drug Market
  • 4.3.1: European Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.3.2: European Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.4: APAC Acne Drug Market
  • 4.4.1: APAC Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.4.2: APAC Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.5: ROW Acne Drug Market
  • 4.5.1: ROW Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.5.2: ROW Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acne Drug Market by Type
  • 6.1.2: Growth Opportunities for the Global Acne Drug Market by Therapeutic Class
  • 6.1.3: Growth Opportunities for the Global Acne Drug Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Acne Drug Market by Region
• 6.2: Emerging Trends in the Global Acne Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acne Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acne Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Bayer
• 7.3: Galderma
• 7.4: Stiefel
• 7.5: Valeant